සැකිල්ල:Infobox drug/testcases

Infobox drug development (Drugbox - talk central, overview, sandboxes, testcases) WT:PHARM

/sandbox: {{Drugbox}} · {{title}} ·  · src {{licence}} ·  · src {{legal}} ·  · src {{pregcat}} ·  · src {{molarmass}} ·  · src {{mab source}} ·  · src {{localINNvar}} ·  · src {{maint cat}} ·  · src {{fmtATC}} ·  · src /format · Infobox drug (/sbox edit diff /test | Source e Talk hist links # /subpages /doc) FDA-2023 {{Infobox drug/doc/FDA-2023}} · /testcases-FDA -- 2023  · /sandbox2 parameters Full parameter list () · Type-conditional sections TPU cats:ප්‍රවර්ගය:Infobox drug tracking categories (7): ප්‍රවර්ගය:Pages using infobox drug with unknown parameters (1) · Parameter usage report cat:IBdrug templates · cat:Templates used in IBdrug testcases (m view): Template:Infobox drug/testcases -- General /testcases2 -- titles, licence, EMA /testcases3 -- pregcat, legal, licence, PLLR, ATC; Wikidata /testcases4 -- chem formula, mab /testcases5 -- identifiers, second id's /testcases6 -- all up /testcases7images -- images /testcases8 -- type, titles /testcases9 -- order variants, container_only /testcases10 -- pharmacokinetic, localINN (2017) has (data page) -- is a redirect /testcases11 -- hormone, gene therapy (2018), has (data page) /testcases-FDA -- FDA 2023 /testcases-warning -- warning box(es) RC recent changes Chem+Drugbox templates · Drugbox transclusions Module:TemplatePar bot Settings.css · Settings/sandbox · {{cascite}} chembox {{Chem/dev/nav}} · {{Chembox}} Infobox drug class (/sbox edit diff /test | Source e Talk hist links # /subpages /doc) විරේචනය

biosimilars

eg Rituximab

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases Clinical data Other names synonyms Biosimilars rituximab-abbs, rituximab-pvvr, rituximab-arrx AHFS/Drugs.com Monograph	Infobox drug/testcases Clinical data Other names synonyms Biosimilars rituximab-abbs, rituximab-pvvr, rituximab-arrx AHFS/Drugs.com Monograph

References

Test Brazilian Legal Status

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases Legal status Legal status AU: S2 (Pharmacy medicine) BR: Class A1 (Narcotic drugs) CA: Schedule I DE: Anlage I (Authorized scientific use only) UK: General sales list (GSL, OTC) US: ℞-only	Infobox drug/testcases Legal status Legal status AU: S2 (Pharmacy medicine) BR: Class A1 (Narcotic drugs) CA: Schedule I DE: Anlage I (Authorized scientific use only) UK: General sales list (GSL, OTC) US: ℞-only

Test 0 = blanks

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases	Infobox drug/testcases

Test 1

විරේචනය

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

Infobox drug/testcases INN: Linezolid Clinical data Pronunciation /njuːˈməʊniə/ Trade names Linospan, Zyvox, Zyvoxam, Zyvoxid Other names Lenzomore AHFS/Drugs.com Monograph MedlinePlus a602004 License data EU EMA: by INN US DailyMed: Linezolid US FDA: Linezolid Pregnancy category AU: C Dependence liability High Addiction liability Low Routes of administration Intravenous infusion, oral ATC code J01XX08 (WHO) Pharmacokinetic data Bioavailability ~100% (oral) Protein binding Low (31%) Metabolism Hepatic (50–70%, CYP not involved) Metabolites some stuff Onset of action 1 hr Elimination half-life 4.2–5.4 hours (shorter in children) Duration of action 1 to 3 hr Excretion Nonrenal, renal, and fecal Identifiers IUPAC name (S)-N-({3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide CAS Number 165800-03-3 Y[??] PubChem CID 441401 IUPHAR/BPS 1234 DrugBank DB00601 UNII ISQ9I6J12J KEGG D00947 Y ChEMBL ChEMBL126 Y NIAID ChemDB 070944 PDB ligand ZLD (PDBe, RCSB PDB) Chemical and physical data Formula C16H20FN3O4 Molar mass 337.346 g/mol 3D model (JSmol) Interactive image Density 1.40 g/cm3 Melting point 135 °C (275 °F) Boiling point 140 °C (284 °F) (decomposes) Solubility in water 3 mg/mL (20 °C) SMILES O=C1O[C@@H](CNC(=O)C)CN1c3cc(F)c(N2CCOCC2)cc3 InChI InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1 Y Key:TYZROVQLWOKYKF-ZDUSSCGKSA-N Y  NY (what is this?)  (verify)

Infobox drug/testcases INN: Linezolid Clinical data Pronunciation /njuːˈməʊniə/ Trade names Linospan, Zyvox, Zyvoxam, Zyvoxid Other names Lenzomore AHFS/Drugs.com Monograph MedlinePlus a602004 License data EU EMA: by INN US DailyMed: Linezolid US FDA: Linezolid Pregnancy category AU: C Dependence liability High Addiction liability Low Routes of administration Intravenous infusion, oral ATC code J01XX08 (WHO) Pharmacokinetic data Bioavailability ~100% (oral) Protein binding Low (31%) Metabolism Hepatic (50–70%, CYP not involved) Metabolites some stuff Onset of action 1 hr Elimination half-life 4.2–5.4 hours (shorter in children) Duration of action 1 to 3 hr Excretion Nonrenal, renal, and fecal Identifiers IUPAC name (S)-N-({3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide CAS Number 165800-03-3 Y[??] PubChem CID 441401 IUPHAR/BPS 1234 DrugBank DB00601 UNII ISQ9I6J12J KEGG D00947 Y ChEMBL ChEMBL126 Y NIAID ChemDB 070944 PDB ligand ZLD (PDBe, RCSB PDB) Chemical and physical data Formula C16H20FN3O4 Molar mass 337.346 g/mol 3D model (JSmol) Interactive image Density 1.40 g/cm3 Melting point 135 °C (275 °F) Boiling point 140 °C (284 °F) (decomposes) Solubility in water 3 mg/mL (20 °C) SMILES O=C1O[C@@H](CNC(=O)C)CN1c3cc(F)c(N2CCOCC2)cc3 InChI InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1 Y Key:TYZROVQLWOKYKF-ZDUSSCGKSA-N Y  NY (what is this?)  (verify)

විරේචනය

Test 2

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

Infobox drug/testcases Clinical data Pronunciation /njuːˈməʊniə/ Other names 3{[(4-cyclopentyl-1-piperazinyl)imino]methyl}rifamycin AHFS/Drugs.com Monograph MedlinePlus a602026 ATC code J04AB05 (WHO) Pharmacokinetic data Bioavailability increases when administered with food Onset of action 1 hr Identifiers IUPAC name (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-26-{[(4-cyclopentylpiperazin-1-yl)amino]methylidene}-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl acetate CAS Number 61379-65-5 PubChem CID 5462354 DrugBank APRD01217 ChemSpider 10482075 Y UNII XJM390A33U KEGG D00879 N ChEBI CHEBI:45304 N ChEMBL ChEMBL1660 N NIAID ChemDB 007686 Chemical and physical data Formula C47H64N4O12 Molar mass 877.031 g/mol 3D model (JSmol) Interactive image SMILES CC(=O)O[C@H]3[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(\C)C(=O)Nc6c(/C=N/N1CCN(CC1)C2CCCC2)c(O)c5c4C(=O)[C@@](C)(O/C=C/[C@H](OC)[C@H]3C)Oc4c(C)c(O)c5c6O InChI InChI=1S/C47H64N4O12/c1-24-13-12-14-25(2)46(59)49-37-32(23-48-51-20-18-50(19-21-51)31-15-10-11-16-31)41(56)34-35(42(37)57)40(55)29(6)44-36(34)45(58)47(8,63-44)61-22-17-33(60-9)26(3)43(62-30(7)52)28(5)39(54)27(4)38(24)53/h12-14,17,22-24,26-28,31,33,38-39,43,53-57H,10-11,15-16,18-21H2,1-9H3,(H,49,59)/b13-12+,22-17+,25-14-,48-23+/t24-,26+,27+,28+,33-,38-,39+,43+,47-/m0/s1 Y Commenting here Key:WDZCUPBHRAEYDL-GZAUEHORSA-N Y  NY (what is this?)  (verify)

Infobox drug/testcases Clinical data Pronunciation /njuːˈməʊniə/ Other names 3{[(4-cyclopentyl-1-piperazinyl)imino]methyl}rifamycin AHFS/Drugs.com Monograph MedlinePlus a602026 ATC code J04AB05 (WHO) Pharmacokinetic data Bioavailability increases when administered with food Onset of action 1 hr Identifiers IUPAC name (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-26-{[(4-cyclopentylpiperazin-1-yl)amino]methylidene}-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl acetate CAS Number 61379-65-5 PubChem CID 5462354 DrugBank APRD01217 ChemSpider 10482075 Y UNII XJM390A33U KEGG D00879 N ChEBI CHEBI:45304 N ChEMBL ChEMBL1660 N NIAID ChemDB 007686 Chemical and physical data Formula C47H64N4O12 Molar mass 877.031 g/mol 3D model (JSmol) Interactive image SMILES CC(=O)O[C@H]3[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(\C)C(=O)Nc6c(/C=N/N1CCN(CC1)C2CCCC2)c(O)c5c4C(=O)[C@@](C)(O/C=C/[C@H](OC)[C@H]3C)Oc4c(C)c(O)c5c6O InChI InChI=1S/C47H64N4O12/c1-24-13-12-14-25(2)46(59)49-37-32(23-48-51-20-18-50(19-21-51)31-15-10-11-16-31)41(56)34-35(42(37)57)40(55)29(6)44-36(34)45(58)47(8,63-44)61-22-17-33(60-9)26(3)43(62-30(7)52)28(5)39(54)27(4)38(24)53/h12-14,17,22-24,26-28,31,33,38-39,43,53-57H,10-11,15-16,18-21H2,1-9H3,(H,49,59)/b13-12+,22-17+,25-14-,48-23+/t24-,26+,27+,28+,33-,38-,39+,43+,47-/m0/s1 Y Commenting here Key:WDZCUPBHRAEYDL-GZAUEHORSA-N Y  NY (what is this?)  (verify)

References

Test 3

Side by side comparison

{{Infobox drug}}	{{Infobox drug/sandbox}}
Infobox drug/testcases Vaccine description Target Tuberculosis Vaccine type Live bacteria Clinical data Pronunciation /njuːˈməʊniə/ AHFS/Drugs.com FDA Professional Drug Information Routes of administration Percutaneous ATC code J07AN01 (WHO) Legal status Legal status US: ℞-only Identifiers ChemSpider NA	Infobox drug/testcases Vaccine description Target Tuberculosis Vaccine type Live bacteria Clinical data Pronunciation /njuːˈməʊniə/ AHFS/Drugs.com FDA Professional Drug Information Routes of administration Percutaneous ATC code J07AN01 (WHO) Legal status Legal status US: ℞-only Identifiers ChemSpider NA

Test 4

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

Infobox drug/testcases Clinical data Pronunciation /njuːˈməʊniə/ Trade names Lipitor, Atorva AHFS/Drugs.com Monograph MedlinePlus a600045 License data US DailyMed: 42465 US FDA: Atorvastatin Pregnancy category AU: D Routes of administration Oral ATC code C10AA05 (WHO) Legal status Legal status AU: S4 (Prescription only) UK: POM (Prescription only) US: ℞-only Pharmacokinetic data Bioavailability 12% Metabolism Hepatic - CYP3A4 Onset of action 1 hr Elimination half-life 14 h Excretion Bile Identifiers IUPAC name (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid CAS Number 134523-00-5 Y[??] PubChem CID 60823 IUPHAR/BPS 2949 DrugBank APRD00055සැකිල්ල:Drugbankcite ChemSpider 54810 Y UNII A0JWA85V8F KEGG D07474 Y ChEBI CHEBI:39548 Y ChEMBL ChEMBL1487 Y PDB ligand 117 (PDBe, RCSB PDB) Chemical and physical data Formula C33H35Ca2FN2O5 Molar mass 558.64 3D model (JSmol) Interactive image SMILES O=C(O)C[C@H](O)C[C@H](O)CCn2c(c(c(c2c1ccc(F)cc1)c3ccccc3)C(=O)Nc4ccccc4)C(C)C InChI InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1 Y Key:XUKUURHRXDUEBC-KAYWLYCHSA-N Y  NY (what is this?)  (verify)

Infobox drug/testcases Clinical data Pronunciation /njuːˈməʊniə/ Trade names Lipitor, Atorva AHFS/Drugs.com Monograph MedlinePlus a600045 License data US DailyMed: 42465 US FDA: Atorvastatin Pregnancy category AU: D Routes of administration Oral ATC code C10AA05 (WHO) Legal status Legal status AU: S4 (Prescription only) UK: POM (Prescription only) US: ℞-only Pharmacokinetic data Bioavailability 12% Metabolism Hepatic - CYP3A4 Onset of action 1 hr Elimination half-life 14 h Excretion Bile Identifiers IUPAC name (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid CAS Number 134523-00-5 Y[??] PubChem CID 60823 IUPHAR/BPS 2949 DrugBank APRD00055සැකිල්ල:Drugbankcite ChemSpider 54810 Y UNII A0JWA85V8F KEGG D07474 Y ChEBI CHEBI:39548 Y ChEMBL ChEMBL1487 Y PDB ligand 117 (PDBe, RCSB PDB) Chemical and physical data Formula C33H35Ca2FN2O5 Molar mass 558.64 3D model (JSmol) Interactive image SMILES O=C(O)C[C@H](O)C[C@H](O)CCn2c(c(c(c2c1ccc(F)cc1)c3ccccc3)C(=O)Nc4ccccc4)C(C)C InChI InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1 Y Key:XUKUURHRXDUEBC-KAYWLYCHSA-N Y  NY (what is this?)  (verify)

Test all 1

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

1 some images Clinical data Pronunciation /njuːˈməʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers IUPAC name 12 CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula 74 Molar mass 75 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 note83 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

1 some images Clinical data Pronunciation /njuːˈməʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers IUPAC name 12 CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula 74 Molar mass 75 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 note83 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

Test all 2

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

1 some images Combination of 17 18 19 20 21 22 23 24 Clinical data Pronunciation /njuːˈməʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 Chemical and physical data Formula 74 Molar mass 75 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

1 some images Combination of 17 18 19 20 21 22 23 24 Clinical data Pronunciation /njuːˈməʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 Chemical and physical data Formula 74 Molar mass 75 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

Test all 3

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

1 some images Vaccine description Target 13 Vaccine type Toxoid Clinical data Pronunciation /njuːˈməʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 Chemical and physical data Formula 74 Molar mass 75 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

1 some images Vaccine description Target 13 Vaccine type Toxoid Clinical data Pronunciation /njuːˈməʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 Chemical and physical data Formula 74 Molar mass 75 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

Test all 4

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

1 some images Monoclonal antibody Type F(ab')2 fragment Source Chimeric (rat/human) Target 13 Clinical data Pronunciation /njuːˈməʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Addiction liability 43b Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula 74 Molar mass 75 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

1 some images Monoclonal antibody Type F(ab')2 fragment Source Chimeric (rat/human) Target 13 Clinical data Pronunciation /njuːˈməʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Addiction liability 43b Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula 74 Molar mass 75 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

Test formula 1

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

1 some images Clinical data Pronunciation /njuːˈməʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers IUPAC name 12 CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula CH2Ag3Al4As5Au6B7Bi8−1 Molar mass 75 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

1 some images Clinical data Pronunciation /njuːˈməʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers IUPAC name 12 CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula CH2Ag3Al4As5Au6B7Bi8−1 Molar mass 75 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

Test formula 2

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

1 some images Clinical data Pronunciation /njuːˈməʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers IUPAC name 12 CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula CBr9Ca10Cl11Co12Cr13F14Fe15Gd16Hg17−1 Molar mass 75 3D model (JSmol) Interactive image Specific rotation 90 Density note83 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

1 some images Clinical data Pronunciation /njuːˈməʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers IUPAC name 12 CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula CBr9Ca10Cl11Co12Cr13F14Fe15Gd16Hg17−1 Molar mass 75 3D model (JSmol) Interactive image Specific rotation 90 Density note83 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

Test formula 3

Side by side comparison

{{Infobox drug}}

{{Infobox drug/sandbox}}

1 some images Clinical data Pronunciation /njuːˈməʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers IUPAC name 12 CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula I18K19Li20Mg21Mn22N23Na24O25P26Pt27−1 Molar mass 75 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

1 some images Clinical data Pronunciation /njuːˈməʊniə/ Trade names 25 Other names 72 AHFS/Drugs.com 27 MedlinePlus 29 License data EU EMA: by INN US DailyMed: 32 US FDA: 31 Pregnancy category AU: B3 35 Dependence liability 43 Routes of administration 44 ATC code 5455 (WHO) 56 Legal status Legal status AU: S4 (Prescription only) CA: Schedule IV UK: POM (Prescription only) US: Schedule III UN: Narcotic Schedules II and III EU: Category 2 Precursor In general: ℞ (Prescription only) Pharmacokinetic data Bioavailability 45 Protein binding 46 Metabolism 47 Onset of action 47.5 Elimination half-life 48 Excretion 49 Identifiers IUPAC name 12 CAS Number 5051 52 PubChem CID 57 PubChem SID 58 IUPHAR/BPS 59 DrugBank 60 ChemSpider 6162 UNII 63 KEGG 6566 ChEBI CHEBI:6768 ChEMBL ChEMBL6970 NIAID ChemDB 71 PDB ligand 73 (PDBe, RCSB PDB) Chemical and physical data Formula I18K19Li20Mg21Mn22N23Na24O25P26Pt27−1 Molar mass 75 3D model (JSmol) Interactive image Specific rotation 90 Density 83 g/cm3 Melting point 84 to 85 °C (183 to 185 °F) 86 Boiling point 87 °C (189 °F) 88 Solubility in water 89 mg/mL (20 °C) SMILES 76 InChI InChI=7779 78 Key:8082   (verify)

Test formula 4

සැකිල්ල:Testcase table